Dr. Mariano Barbacid, a pioneering Spanish cancer scientist, alongside his team have eliminated aggressive pancreatic tumours ...

Spanish researchers report a major pancreatic cancer breakthrough in mice, with a triple-drug therapy eliminating tumours by ...

Barbacid's innovative approach targets three critical components involved in pancreatic cancer: KRAS, EGFR, and STAT3. KRAS mutations are present in 90% of pancreatic cancer cases, making it a focal ...

A Visionary in Oncology Mariano Barbacid is a prominent figure in cancer research, known for his unwavering dedication to understanding and combating cancer. His recent address to students in Santiago ...

Pancreatic cancer is considered one of the most aggressive tumours. Not only does this cancer come with the worst prognosis, but also it shows resistance to treatment. However, the recent ...

A Spanish research team has achieved a significant preclinical breakthrough, developing a triple-drug therapy that completely ...

With 2026 set to be a banner year for M&A as buyers facing patent cliffs compete for a limited pool of late-stage assets ( [3]) , companies demonstrating disciplined pivotal execution and FDA ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...

Led by renowned cancer biologist Dr Mariano Barbacid, a group of Spanish researchers have created a drug-based cure that can kill pancreatic cancer tumors in the body and eliminate the disease ...